|
2GMO
NMR-structure of an independently folded C-terminal domain of influenza polymerase subunit PB2
Deposited 2006-04-07
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
678–759(82 aa)
Fragment:PB2 C-terminal 678-759 fragment
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;283 K;Ionic strength (raw mmCIF value) 200 mM NaCl;Pressure ambient
NMR sample composition
50 mM Tris buffer pH 7.5, 200 mM NaCl, 1 mM EDTA, 0.01% NaN3, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
50 mM Tris buffer pH 7.5, 200 mM NaCl, 1 mM EDTA, 0.01% NaN3, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2VQZ
Structure of the cap-binding domain of influenza virus polymerase subunit PB2 with bound m7GTP
Deposited 2008-03-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
318–483(166 aa)
Fragment:CAP-BINDING DOMAIN, RESIDUES 318-483
Chain B
318–483(166 aa)
Fragment:CAP-BINDING DOMAIN, RESIDUES 318-483
Chain D
318–483(166 aa)
Fragment:CAP-BINDING DOMAIN, RESIDUES 318-483
Chain E
318–483(166 aa)
Fragment:CAP-BINDING DOMAIN, RESIDUES 318-483
Chain F
318–483(166 aa)
Fragment:CAP-BINDING DOMAIN, RESIDUES 318-483
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MGT 7N-METHYL-8-HYDROGUANOSINE-5'-TRIPHOSPHATE × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;1 MICROLITRE OF PROTEIN SOLUTION AT 11 MG PER ML IN 50 MM TRIS-HCL (PH 8.0), 200 MM NACL, 2 MM DTT, 5 MM M7GTP WITH AN EQUAL VOLUME OF A SOLUTION CONTAINING 0.1 M CITRIC ACID PH 4.6, 1.6-1.8 M SODIUM FORMATE.
|
Resolution 2.30 Å
R-free 0.235
|
|
2VY6
Two domains from the C-terminal region of influenza A virus polymerase PB2 subunit
Deposited 2008-07-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
538–753(216 aa)
Fragment:627- AND NLS-DOMAINS, RESIDUES 538-753
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1 MICROLITRE OF 5.5 MG/ML PROTEIN SOLUTION IN 10 MM TRIS-HCL PH 7.0 AND 200 MM NACL WITH EQUAL VOLUME OF 100 MM HEPES PH 7.5 AND K/NA TARTRATE AT 1.2 M.
|
Resolution 1.95 Å
R-free 0.258
|
|
2VY7
The 627-domain from influenza A virus polymerase PB2 subunit
Deposited 2008-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
538–693(156 aa)
Fragment:627- DOMAIN, RESIDUES 538-693
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1 MICROLITRE OF 2.4 MG/ML PROTEIN SOLUTION IN 10 MM TRIS-HCL PH 7.0 AND 200 MM NACL WITH 1 MICROLITRE OF 100 MM CITRIC ACID PH 4.0-7.0 AND 1.4-1.6 M AMMONIUM SULFATE SOLUTION
|
Resolution 1.53 Å
R-free 0.185
|
|
2VY8
The 627-domain from influenza A virus polymerase PB2 subunit with Glu- 627
Deposited 2008-07-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
538–693(156 aa)
Fragment:627-DOMAIN, RESIDUES 538-693
|
Mutation:YES
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1 MICROLITRE OF 2.4 MG/ML PROTEIN SOLUTION IN 10 MM TRIS-HCL PH 7.0 AND 200 MM NACL WITH 1 MICROLITRE OF 100 MM CITRIC ACID PH 4.0-7.0 AND 1.4-1.6 M AMMONIUM SULFATE SOLUTION
|
Resolution 1.20 Å
R-free 0.214
|
|
4NCE
Influenza polymerase basic protein 2 (PB2) bound to 7-methyl-GTP
Deposited 2013-10-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
317–483(167 aa)
Fragment:CAP-BINDING DOMAIN
|
Mutation:R389K
|
MGT 7N-METHYL-8-HYDROGUANOSINE-5'-TRIPHOSPHATE × 1
11H 9,10-dioxo-9,10-dihydroanthracene-2,6-disulfonic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.7;298 K;0.7 uL of protein solution (9.7 mg/mL protein, 50 mM Tris buffer pH 8, 200 mM sodium chloride, 2 mM dithiothreitol, 5 mM m7GTP) was mixed with 0.35 uL Hampton Research Silver Bullet screening reagent #36. This mixture was combined with 0.35 uL of well solution (approximately 1.3 M sodium formate, 100 mM sodium citrate buffer pH 4.6, 5 mM dithiothreitol) and suspended over 1 mL of well solution, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.229
|
|
4NCM
Influenza polymerase basic protein 2 (PB2) bound to a small-molecule inhibitor
Deposited 2013-10-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
317–483(167 aa)
Fragment:CAP-BINDING DOMAIN
|
Mutation:R389K
|
704 N~2~-[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]-N,N-dimethyl-L-alaninamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.7;298 K;0.7 uL of protein solution (9.7 mg/mL protein, 50 mM Tris buffer pH 8, 200 mM sodium chloride, 2 mM dithiothreitol, 5 mM m7GTP) was mixed with 0.35 uL Hampton Research Silver Bullet screening reagent #36. This mixture was combined with 0.35 uL of well solution (approximately 1.3 M sodium formate, 100 mM sodium citrate buffer pH 4.6, 5 mM dithiothreitol) and suspended over 1 mL of well solution, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.82 Å
R-free 0.191
|
|
4P1U
Influenza A (flu) virus polymerase basic protein 2 (PB2) bound to VX787, an azaindole inhibitor
Deposited 2014-02-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
318–483(166 aa)
|
Not recorded
|
21G (2S,3S)-3-[[5-fluoranyl-2-(5-fluoranyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.7;293 K;1 ?L protein solution (2.8 mg/ml protein, 50 mM Tris buffer pH 8, 200 mM sodium chloride, 2 mM dithiothreitol, 1 mM anthraquinone-2,6-disulfonic acid disodium salt, 7.5 mM GTP) and 0.4 ?L well solution (1.5 M sodium formate, 100 mM sodium citrate buffer pH 4.7, 10 mM dithiothreitol) was suspended over 1 mL of well solution. The crystals were transferred to a soaking solution (3.25 M sodium formate, 100 mM sodium citrate buffer pH 4.7) containing 1 mM VRT-0928787. Crystals were incubated approximately 15 hours t room temperature, and then transferred to a cryo-preservative solution (soaking solution with 25 % v/v glycerol) prior to freezing in liquid nitrogen.
|
Resolution 2.52 Å
R-free 0.243
|
|
4UAD
Importin alpha 7 delta IBB in complex with Influenza PB2 Nuclear Localization Domain
Deposited 2014-08-08
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
683–759(77 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M magnesium acetate
12% PEG 8000
0.1M Na cacodylate at pH 6.5
|
Resolution 2.42 Å
R-free 0.231
|
|
4UAE
Importin alpha 3 delta IBB in complex with Influenza PB2 Nuclear Localization Domain
Deposited 2014-08-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
678–759(82 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.1 M Na cacodylate, pH 6.5
0.1 M NaCl
1.1 M ammonium sulfate
|
Resolution 2.70 Å
R-free 0.239
|
|
4UAF
Importin alpha 1 delta IBB in complex with Influenza PB2 nuclear localization domain
Deposited 2014-08-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
678–759(82 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.49 M Na phosphate monobasic
0.91 M K phosphate dibasic
pH 6.9
|
Resolution 1.70 Å
R-free 0.193
|
|
6EUV
Structure of the midlink and cap-binding domains of influenza A polymerase PB2 subunit with a bound azaindole cap-binding inhibitor (VX-787)
Deposited 2017-10-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
247–536(290 aa)
|
Not recorded
|
21G (2S,3S)-3-[[5-fluoranyl-2-(5-fluoranyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 2
NI NICKEL (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;Crystals were obtained by mixing protein at 16 mg per mL mixed with 2 mM VX-787 in 0.1 M MES pH6, 0.7 M sodium formate pH 6.
|
Resolution 2.70 Å
R-free 0.282
|
|
6EUV
Structure of the midlink and cap-binding domains of influenza A polymerase PB2 subunit with a bound azaindole cap-binding inhibitor (VX-787)
Deposited 2017-10-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
247–536(290 aa)
|
Not recorded
|
21G (2S,3S)-3-[[5-fluoranyl-2-(5-fluoranyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 2
NI NICKEL (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;Crystals were obtained by mixing protein at 16 mg per mL mixed with 2 mM VX-787 in 0.1 M MES pH6, 0.7 M sodium formate pH 6.
|
Resolution 2.70 Å
R-free 0.282
|
|
6EUV
Structure of the midlink and cap-binding domains of influenza A polymerase PB2 subunit with a bound azaindole cap-binding inhibitor (VX-787)
Deposited 2017-10-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain F
247–536(290 aa)
|
Not recorded
|
21G (2S,3S)-3-[[5-fluoranyl-2-(5-fluoranyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
NI NICKEL (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;Crystals were obtained by mixing protein at 16 mg per mL mixed with 2 mM VX-787 in 0.1 M MES pH6, 0.7 M sodium formate pH 6.
|
Resolution 2.70 Å
R-free 0.282
|
|
6EUV
Structure of the midlink and cap-binding domains of influenza A polymerase PB2 subunit with a bound azaindole cap-binding inhibitor (VX-787)
Deposited 2017-10-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain I
247–536(290 aa)
|
Not recorded
|
21G (2S,3S)-3-[[5-fluoranyl-2-(5-fluoranyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
NI NICKEL (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;Crystals were obtained by mixing protein at 16 mg per mL mixed with 2 mM VX-787 in 0.1 M MES pH6, 0.7 M sodium formate pH 6.
|
Resolution 2.70 Å
R-free 0.282
|
|
6EUY
Structure of the midlink and cap-binding domains of influenza A polymerase PB2 subunit with a bound azaindazole cap-binding inhibitor
Deposited 2017-10-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
247–536(290 aa)
|
Not recorded
|
BYB (2~{S},3~{S})-3-[[5-fluoranyl-2-(5-fluoranyl-1~{H}-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals were obtained with A/H3N2 double domain at 15 mg/ml in 20 mM Tris pH 8, 150 mM NaCl, 5% glycerol, 2 mM beta-mercaptoethanolmixed with 5 mM of VX-787 mixed with 0.2 M ammonium sulphate, 20% PEG3350
|
Resolution 3.00 Å
R-free 0.263
|
|
6EUY
Structure of the midlink and cap-binding domains of influenza A polymerase PB2 subunit with a bound azaindazole cap-binding inhibitor
Deposited 2017-10-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
247–536(290 aa)
|
Not recorded
|
BYB (2~{S},3~{S})-3-[[5-fluoranyl-2-(5-fluoranyl-1~{H}-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals were obtained with A/H3N2 double domain at 15 mg/ml in 20 mM Tris pH 8, 150 mM NaCl, 5% glycerol, 2 mM beta-mercaptoethanolmixed with 5 mM of VX-787 mixed with 0.2 M ammonium sulphate, 20% PEG3350
|
Resolution 3.00 Å
R-free 0.263
|
|
6EUY
Structure of the midlink and cap-binding domains of influenza A polymerase PB2 subunit with a bound azaindazole cap-binding inhibitor
Deposited 2017-10-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
247–536(290 aa)
|
Not recorded
|
BYB (2~{S},3~{S})-3-[[5-fluoranyl-2-(5-fluoranyl-1~{H}-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals were obtained with A/H3N2 double domain at 15 mg/ml in 20 mM Tris pH 8, 150 mM NaCl, 5% glycerol, 2 mM beta-mercaptoethanolmixed with 5 mM of VX-787 mixed with 0.2 M ammonium sulphate, 20% PEG3350
|
Resolution 3.00 Å
R-free 0.263
|
|
7XME
Structure of Influenza A virus polymerase basic protein 2 (PB2) with an azazindole derivative
Deposited 2022-04-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
318–483(166 aa)
|
Not recorded
|
IOD IODIDE ION × 1
GIH (2~{S},3~{S})-3-[[5-dimethoxyphosphoryl-4-(5-fluoranyl-1~{H}-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;277.15 K;Soudium,BIS-Tris propane pH 8.5,PEG3350
|
Resolution 2.52 Å
R-free 0.330
|
|
7XME
Structure of Influenza A virus polymerase basic protein 2 (PB2) with an azazindole derivative
Deposited 2022-04-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
318–483(166 aa)
|
Not recorded
|
IOD IODIDE ION × 1
GIH (2~{S},3~{S})-3-[[5-dimethoxyphosphoryl-4-(5-fluoranyl-1~{H}-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;277.15 K;Soudium,BIS-Tris propane pH 8.5,PEG3350
|
Resolution 2.52 Å
R-free 0.330
|
|
7XME
Structure of Influenza A virus polymerase basic protein 2 (PB2) with an azazindole derivative
Deposited 2022-04-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
318–483(166 aa)
|
Not recorded
|
IOD IODIDE ION × 1
GIH (2~{S},3~{S})-3-[[5-dimethoxyphosphoryl-4-(5-fluoranyl-1~{H}-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;277.15 K;Soudium,BIS-Tris propane pH 8.5,PEG3350
|
Resolution 2.52 Å
R-free 0.330
|
|
7XME
Structure of Influenza A virus polymerase basic protein 2 (PB2) with an azazindole derivative
Deposited 2022-04-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
318–483(166 aa)
|
Not recorded
|
IOD IODIDE ION × 1
GIH (2~{S},3~{S})-3-[[5-dimethoxyphosphoryl-4-(5-fluoranyl-1~{H}-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;277.15 K;Soudium,BIS-Tris propane pH 8.5,PEG3350
|
Resolution 2.52 Å
R-free 0.330
|
|
9V44
Coupling of polymerase-nucleoprotein-RNA in an influenza virus mini ribonucleoprotein complex
Deposited 2025-05-22
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain C
1–759(759 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.97 Å
|
|
9V46
Coupling of polymerase-nucleoprotein-RNA in an influenza virus mini ribonucleoprotein complex
Deposited 2025-05-22
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 3
PDB declaration: pentameric
|
Chain C
1–759(759 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.62 Å
|